PURPOSE: This study aimed to develop and validate a scoring system to identify long-term survivors after conventional radiotherapy (RT) for metastatic spinal cord compression (MSCC). PATIENTS AND METHODS: Data from 1,125 patients who had received long-course RT for MSCC were included in this study. Of these patients, 344 survived for over 12 months and 781 died within a year following RT. Based on differences between the distributions of patient characteristics in the two groups, a scoring system was developed. Scores ranged from 0 to 18 points and 15 points was selected as the cutoff for identifying long-term survivors. Data from the 1,125 long-course RT patients (test group) were compared to data from 773 patients receiving short-course RT (validation group). RESULTS: A score of ≥ 15 points was associated with a 94 % proportion of long-term survivors. The 15-point cutoff resulted in a specificity of 98 % and a positive predictive value of 94 % for identification of long-term surviving patients. The proportions of long-term survivors for each scoring point in the validation group were very similar to those in the test group. CONCLUSION: This new scoring system enabled identification of long-term survivors after RT for MSCC with very high specificity and positive predictive value. The score proved to be valid and reproducible.
PURPOSE: This study aimed to develop and validate a scoring system to identify long-term survivors after conventional radiotherapy (RT) for metastatic spinal cord compression (MSCC). PATIENTS AND METHODS: Data from 1,125 patients who had received long-course RT for MSCC were included in this study. Of these patients, 344 survived for over 12 months and 781 died within a year following RT. Based on differences between the distributions of patient characteristics in the two groups, a scoring system was developed. Scores ranged from 0 to 18 points and 15 points was selected as the cutoff for identifying long-term survivors. Data from the 1,125 long-course RT patients (test group) were compared to data from 773 patients receiving short-course RT (validation group). RESULTS: A score of ≥ 15 points was associated with a 94 % proportion of long-term survivors. The 15-point cutoff resulted in a specificity of 98 % and a positive predictive value of 94 % for identification of long-term surviving patients. The proportions of long-term survivors for each scoring point in the validation group were very similar to those in the test group. CONCLUSION: This new scoring system enabled identification of long-term survivors after RT for MSCC with very high specificity and positive predictive value. The score proved to be valid and reproducible.
Authors: Dirk Rades; Stefan Huttenlocher; Amira Bajrovic; Johann H Karstens; Irenaeus A Adamietz; Nadja Kazic; Volker Rudat; Steven E Schild Journal: Int J Radiat Oncol Biol Phys Date: 2011-01-27 Impact factor: 7.038
Authors: Dirk Rades; Sarah Douglas; Theo Veninga; Lukas J A Stalpers; Peter J Hoskin; Amira Bajrovic; Irenaeus A Adamietz; Hiba Basic; Juergen Dunst; Steven E Schild Journal: Cancer Date: 2010-08-01 Impact factor: 6.860
Authors: Samuel Ryu; Jack Rock; Rajan Jain; Mei Lu; Joseph Anderson; Jian-Yue Jin; Mark Rosenblum; Benjamin Movsas; Jae Ho Kim Journal: Cancer Date: 2010-05-01 Impact factor: 6.860
Authors: D Rades; S Douglas; T Veninga; A Bajrovic; L J A Stalpers; P J Hoskin; V Rudat; S E Schild Journal: Strahlenther Onkol Date: 2012-02-25 Impact factor: 3.621
Authors: Amit K Garg; Almon S Shiu; James Yang; Xin-Shelley Wang; Pamela Allen; Barry W Brown; Patricia Grossman; Erik K Frija; Mary Frances McAleer; Syed Azeem; Paul D Brown; Laurence D Rhines; Eric L Chang Journal: Cancer Date: 2012-04-17 Impact factor: 6.860
Authors: Peter S Rose; Ilya Laufer; Patrick J Boland; Andrew Hanover; Mark H Bilsky; Josh Yamada; Eric Lis Journal: J Clin Oncol Date: 2009-09-08 Impact factor: 44.544
Authors: John W Nelson; David S Yoo; John H Sampson; Robert E Isaacs; Nicole A Larrier; Lawrence B Marks; Fang-Fang Yin; Q Jackie Wu; Zhiheng Wang; John P Kirkpatrick Journal: Int J Radiat Oncol Biol Phys Date: 2008-11-10 Impact factor: 7.038
Authors: Frederick Mantel; Stefan Glatz; André Toussaint; Michael Flentje; Matthias Guckenberger Journal: Strahlenther Onkol Date: 2014-06-27 Impact factor: 3.621
Authors: Harald Rief; Rita C Heinhold; Lina C Petersen; Stefan Rieken; Thomas Bruckner; Arash Moghaddam-Alvandi; Jürgen Debus; Florian Sterzing Journal: Radiat Oncol Date: 2013-12-28 Impact factor: 3.481